Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Quantum Genesis AI (QTZM) EBT Margin (2016 - 2018)

Quantumzyme's EBT Margin history spans 4 years, with the latest figure at 0.61% for Q2 2018.

  • For Q2 2018, EBT Margin fell 2738.0% year-over-year to 0.61%; the TTM value through Oct 2024 reached 293.26%, changed N/A, while the annual FY2018 figure was 30.11%, 6.0% up from the prior year.
  • EBT Margin reached 0.61% in Q2 2018 per QTZM's latest filing, up from 1.32% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 27.99% in Q2 2017 to a low of 90.47% in Q4 2016.
  • Average EBT Margin over 4 years is 12.84%, with a median of 1.32% recorded in 2018.
  • Peak YoY movement for EBT Margin: crashed -8323bps in 2016, then surged 8242bps in 2017.
  • A 4-year view of EBT Margin shows it stood at 7.24% in 2015, then plummeted by -1150bps to 90.47% in 2016, then surged by 91bps to 8.05% in 2017, then soared by 108bps to 0.61% in 2018.
  • Per Business Quant, the three most recent readings for QTZM's EBT Margin are 0.61% (Q2 2018), 1.32% (Q1 2018), and 8.05% (Q4 2017).